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Abstract
PURPOSE—To test whether different-sized iron oxide– containing Embosphere (IOE) particles
can be detected by dedicated magnetic resonance (MR) imaging when injected intraarterially in an
animal model of liver cancer and whether their distribution could be accurately predicted by MR
imaging before confirmation with histopathologic analysis.
MATERIALS AND METHODS—Twenty New Zealand White rabbits implanted with VX2 liver
tumor were randomly assigned to undergo embolization with 100 –300-µm particles (group S; n =
10) or 300 –500-µm particles (group L; n = 10). Embolization was performed with the catheter placed
in the proper hepatic artery. T2*-weighted multiplanar MR imaging was performed within 24 hours
after the procedure to detect paramagnetic IOE susceptibility artifact. MR imaging interpretation
parameters included presence of artifact in the artery and/or at the tumor bed. Hematoxylin and eosin–
and Prussian blue–stained pathologic slides were also obtained and the presence of IOE was evaluated
similarly.
RESULTS—The MR detectability rates for IOEs were 100% in both groups. Paramagnetic
susceptibility IOE artifact inside the tumor was detected in 30% of group S animals. On pathologic
analysis, IOE particles were detected inside the tumor in 70% of this group. IOEs in group L were
found outside the tumor within the hepatic artery on MR imaging and histopathologic study (P < .
05).
CONCLUSIONS—MR imaging readily detected IOE particles in an animal model of liver cancer
regardless of the particle size. The smaller particles (100 –300 µm) were delivered inside the tumor
or in close proximity to the tumor margin, justifying their use for drug delivery or precise
embolization.
Embolization of liver tumors, in the form of bland embolization, transcatheter arterial
chemoembolization, or radioembolization with yttrium-90, is one of the most commonly
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performed interventional radiologic procedures for the treatment of patients with primary or
secondary liver cancer (1–4). Various embolic devices with different morphologic, chemical,
and physiomechanical properties are currently employed during these procedures (3) . Among
the most commonly used embolic devices are microspheres, which can be made of resorbable
or nonresorbable materials, easily calibrated and accurately graded, or effectively drug-loaded
and copolymerized with other biocompatible compounds (5–10).
Magnetic resonance (MR) imaging is attractive as an imaging technique because it combines
the benefits of high spatial resolution with physiologic information on a specific area. The
introduction of iron as an integral component of microspheres is appealing because the presence
of ferromagnetic material within tissue can be easily detected on MR imaging (11–13). Until
the present time, iron-loaded embolic microspheres have been mainly used with the concurrent
application of an external alternating magnetic field as a combination of hyperthermia
treatment and permanent vessel occlusion (14).
Tris-acryl gelatin microspheres (Embosphere Microspheres; Biosphere Medical, Rockland,
Massachusetts) are calibrated, hydrophilic, nonresorbable biocompatible embolic
microspheres that are routinely used during liver embolization procedures (3). The choice of
Embosphere size for liver embolization procedures often depends on the operator′s preference,
as there have been no solid data advocating the use of one size versus another (3). Moreover,
delineation of their preferential distribution in the tumor bed has been limited to a few studies
that used invasive or experimental methods (15–17). Therefore, the development of a new class
of embolic microspheres detectable by imaging—and a reliable noninvasive imaging method
capable of identifying the distribution of these microspheres in tumor and nontumorous tissue
—may be of significance when choosing the most appropriate particle size for embolization
or drug delivery.
In this study, we used two different sizes of iron oxide–loaded Embospheres for transcatheter
arterial embolization of the VX2 liver tumor model and subsequently evaluated their
distribution in liver tissue by dedicated MR imaging and histopathologic analysis. We aimed
to assess the feasibility of using such microspheres for liver embolization procedures, evaluate




Our institution′s animal care and use committee approved the study, and all animal care and
use procedures were performed under our institutional guidelines. A total of 24 adult New
Zealand White male rabbits (Myrtle′s Rabbitry, Thompson Station, Tennessee) weighing 3.8–
4.3 kg were used for this study. Four rabbits were used as tumor carriers for the study rabbits
and 20 study rabbits underwent implantation in the liver with VX2 tumor before undergoing
embolization. These study rabbits were then randomly assigned to two groups of 10 animals
each (groups S and L): group S animals received intraarterial hepatic embolization with iron
oxide–containing Embosphere (IOE) microspheres measuring 100–300 µm in size, whereas
group L animals were treated with IOEs measuring 300–500 µm in size. All animals underwent
imaging in a 1.5-T clinical MR imaging scanner within 24 hours after embolization with a
dedicated iron-detecting protocol. All animals were subsequently euthanized after scanning,
and liver and tumor sections were sent for histopathologic analysis of IOE detection and
distribution.
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Anesthesia was induced with an intramuscular injection of acepromazine (2.5 mg/kg; Phoenix,
St. Joseph, Missouri) and ketamine (44 mg/kg; Phoenix) and maintained via a marginal ear
vein with sodium pentobarbital (2.5–5 mg; Abbott Laboratories, North Chicago, Illinois)
during all animal interventions. VX2 tumor cell suspensions were prepared and provided by
J. Hilton, MD. Each rabbit tumor carrier received a single intramuscular injection of 125 µL
of VX2 tumor cell suspensions on each hind leg. After 12–14 days, the intramuscularly grown
tumors were harvested and preserved in normal saline solution until completion of the
implantation procedures, and the carriers were euthanized with slow intravenous injection of
pentobarbital. All VX2 liver tumor implantation procedures were carried out in a sterile
fashion. The liver of each rabbit was exposed with a midline subxiphoid incision, and a single
small tumor piece (approximately 3 mm3) was implanted directly into the left lateral lobe of
the liver. Manual compression over the point of tumor insertion was then applied for 30
seconds, followed by surgical closure of the abdomen in two layers. The tumors were allowed
to grow in the rabbit livers for 13–15 days, after which time a well demarcated solitary tumor
was expected to grow to a size of 1.5–2.0 cm in diameter (18,19). After surgery, the animals
were placed in cages and monitored until they fully recovered from anesthesia.
Preparation of Embolization Material
Iron oxide–containing tris-acryl gelatin microspheres (Biosphere Medical, Rockland,
Massachusetts) were synthesized with use of an emulsion polymerization process involving
tris-acryl monomer and iron oxide nanoparticles. The iron oxide was introduced in the
monomer phase before the polymerization phase. Microspheres were then washed several
times with water and passed through a sieve to isolate several size ranges: 100–300 µm, 300–
500 µm, 500–700 µm and 700–900 µm. The samples were tested at dosages with isomolar iron
content. The iron concentration was optimized in a previous report and standardized at 670 mg
Fe/L (20).
In Vitro MR Imaging
Microspheres from the different size ranges were mixed and dispersed with trypcase soja gel.
The mixture was introduced in glass tubes for imaging evaluation by employing low-resolution
MR imaging (1.5 T, T1 spinecho sequence).
Embolization Materials for Animal Studies
IOE microspheres were provided by the manufacturer in vials of 100 – 300 µm and 300 –500
µm maximum diameters, which were used for all embolization procedures. A total of 5 mL of
particles was diluted in 15 mL of 0.9% sodium chloride and 10 mL contrast medium
(Omnipaque; Amersham, Piscataway, New Jersey), making the total volume of IOE suspension
30 mL.
Transcatheter Hepatic Arterial Embolization Technique
All rabbits were anesthetized and intubated, and their CO2 was monitored throughout the
procedure. Access into the right common femoral artery was obtained via a surgical cut-down,
after which a 3-F sheath (Cook, Bloomington, Indiana) was inserted. A 2-F JB1 catheter (Cook)
was then manipulated into the common hepatic artery and arteriography was performed to
delineate the hepatic arterial anatomy and tumor staining (Fig 1). After adequate catheter
positioning was achieved at the level of the proper hepatic artery, the IOE suspension was
slowly administered under fluoroscopic guidance. The endpoint of the embolization procedure
was lobar arterial inflow reduction with concurrent maintenance of proper hepatic arterial
inflow. After the procedure, the common femoral artery was ligated with absorbable sutures.
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MR Imaging Protocol and Analysis
All animals underwent imaging within 24 hours after embolization with IOE. Baseline MR
imaging was performed before embolization in five animals. All animals were anesthetized
and intubated before imaging. MR imaging was performed at 1.5 T (Signa; General Electric
Medical Systems, Milwaukee, Wisconsin). Each animal was placed inside an extremity coil
and covered with a blanket. Imaging protocol consisted of T2-weighted fast spin-echo images
(matrix size, 128 × 128; slice thickness, 5 mm; interslice gap, 5 mm; repetition/echo times,
1,800/78.62 msec; receive bandwidth, 32 kHz), T1-weighted two-dimensional fat-suppressed
spoiled gradient-echo images (field of view, 16 × 16; matrix, 512 × 192; slice thickness, 5 mm;
repetition/echo times, 150/2.088 msec; receive bandwidth, 64 kHz; flip angle, 15°), and T2*-
weighted multi-planar images (field of view, 16 × 16; matrix size, 256 × 160; repetition/echo
times, 200/15 msec; flip angle, 45°; slice thickness, 5 mm; interslice gap, 5 mm).
Images were evaluated by consensus of two experienced MR imaging radiologists who were
unaware of the histopathologic findings. Qualitative MR imaging interpretation was based on
T2*-weighted images, assuming that the IOEs produce a strong signal reduction artifact in this
sequence. In each T2*-weighted study, the presence or absence of signal voids was first
recorded. In case of present signal decays, the IOE distribution was further described in relation
to two anatomic structures and based on a subjective two-tier scale: (i) artifact in the artery and
(i) artifact in the tumor bed (at the periphery of the tumor or inside the tumor). The presence
of an artifact related to the tumor was further subjectively scored as 1, 2, or both, with 1
indicating artifact in the artery and 2 indicating artifact in the tumor bed at the periphery or
inside the tumor.
Histopathology
Within 1–2 hours after completion of MR imaging, all animals were euthanized under deep
anesthesia by slow intravenous injection of sodium pentobarbital. All livers were then
explanted and preserved in 10% formaldehyde for at least 4 days, after which time gross liver
tumor specimens were cut in 5-mm sections and labeled according to the MR imaging anatomic
orientation. Each section was then embedded in paraffin, and four slices (approximately 4 µm
each) from each section were stained with hematoxylin and eosin and Perls Prussian blue.
All slides were reviewed by an independent pathologist for detection and localization of the
IOE. In each slide, the presence or absence of microspheres was first recorded. In case of
present microspheres, a more detailed evaluation was then performed. Their presence was
scored on a scale similar to the MR scoring scale, with a score of 1 indicating IOE particles in
an artery and a score of 2 indicating IOE particles in the tumor bed at the periphery of the tumor
or inside the tumor.
Statistics
All data were analyzed with the statistical package STATA (version 9; Stata, College Station,
Texas). Statistical analysis included t tests, Wilcoxon rank tests, and Pearson correlation
analysis for all tested parameters. Differences were considered statistically significant at P
values less than .05.
RESULTS
Liver tumor growth was successful in both animal groups, with a consistent mean maximum
tumor diameter of 1.65 cm ± 0.33 (SD), as measured on axial T1-weighted MR images. All
rabbits underwent successful intraarterial embolization. No technical difficulties or
periprocedural complications were observed. A prominent tumor-feeding artery arising off the
left hepatic artery was identified in all cases. In group S, 10 mL of the total 30 mL of IOE
Lee et al. Page 4













suspension was successfully injected according to the endpoint of the embolization procedure,
whereas in group L, 5 mL of the of total 30 mL of IOE solution was injected. This was a result
of the size difference in IOEs used between groups.
The VX2 tumors were identified as spherical or ovoid solid structures within the left hepatic
lobe, with low signal intensity on T1-weighted images, high signal intensity on T2-weighted
images, and relatively high signal intensity on T2*-weighted images. All preembolization
baseline MR imaging performed in five rabbits demonstrated homogenous high signal
intensity, and there were no dark signal intensity spots that could possibly cause false-positive
findings when evaluating the postembolization MR imaging.
After embolization with IOEs, distinctive signal voids representing clusters of IOEs could be
identified in the liver (right and left lobes and gallbladder) and/or in the tumor area.
Quantification of IOE distribution according to size is shown in the Table. T2*-weighted MR
imaging was 100% sensitive in both groups in the detection of signal decay caused by the IOEs.
A signal void in tumor feeding arteries was detected in all cases in both groups. In group S,
the signal void was identified circumferentially around the tumor in all cases and inside the
tumor in 30% of cases (Fig 2). None of the animals in group L showed similar signal decay
inside the tumor (P = .004), but rather, signal dropoff was found partially distributed at the
periphery of the tumor and at a distance from the tumor within the hepatic artery (Fig 3).
Quantification of the artifact revealed a significantly higher score in group S than in group L
(20 vs 16; P < .05).
On histopathologic analysis, IOE particles were identified as bright pink spheres on
hematoxylin and eosin–stained specimens and were translucent with a green rim on Perls
Prussian blue–stained specimens. IOEs were detected inside the tumor in 70% of all group S
animals (Fig 4). Conversely, intratumoral IOE deposition was not detected in any of the group
L animals (P < .05), confirming the MR imaging findings.
There was no significant difference between groups regarding MR artifact in the artery and the
histopathologic presence of particles in the artery (P > .9999). However, there was significant
difference when comparing the MR artifact (P = .0368) and the histopathologic presence of
particles (P = .0051) in the tumor bed between the two groups. There was positive MR imaging
and histopathologic correlation in both groups (Pearson ρ = .667; P = .0332) for the distribution
of IOEs in the tumor bed.
DISCUSSION
Several embolic agents have been employed during the past two decades to maximize the
effects of transcatheter intraarterial therapy for hepatic malignancies (3,19). The level of their
vascular and peri-and intratumoral distribution has been selectively confirmed, mostly by
invasive histopathologic analysis (21,22). Therefore, the fabrication of microspheres that can
be noninvasively detected holds great promise for further refinement of the embolization
technique, as well as determination of particle size for drug delivery. Our study introduces iron
oxide–loaded tris-acryl gelatin microspheres for hepatic embolization procedures, which can
be easily detected and tracked noninvasively by dedicated MR imaging. By tracking the
delivery of these microspheres, such an MR imaging protocol, which is already used clinically,
could provide valuable information on the differences in distribution of these microspheres
based on their size. The results of our study are significant because we showed that IOEs could
indeed be imaged and tracked by MR imaging and that the distribution of these microspheres
within the tumor (or outside the tumor for the larger beads) could have major clinical
implications.
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Two key points should be addressed that have helped us achieve the results described. First,
we diluted the vial of IOE and injected the IOE suspension slowly in accordance with arterial
pulsatility into the tumor-feeding artery. The dilution of the IOE suspension and the slow
pulsatile injection rate not only prevent spasmodic change of the feeding artery that would limit
the amount of embolic agent delivered, they also enable the solution to flow along the
bloodstream toward the tumor bed. As the main feeding artery gradually fills with IOEs, the
flow kinetics decrease and the IOEs travel at a slower speed until they gradually saturate the
feeding vessels. It has been shown that bolus injection of microspheres may lead to particle
congregation and congestion at a more proximal site of the feeding branches (22). Therefore,
it seems that the embolization technique may be initially modified by adapting the volume,
dilution, and injection rate of microspheres.
Second, IOEs are ferromagnetic particles, which tend to agglomerate because of their
permanent magnetic dipoles. One would assume that it could be difficult to achieve successful
targeting without an external magnetic field. However, dilution to decrease the density in the
injected volume and the slow pulsatile injection rate, assisted by the vessel′s normal blood
flow, appeared to overcome the microspheres′ intrinsic magnetic forces. In our study,
microsphere agglomeration was sufficient to cause a distinctive signal void on T2*-weighted
MR imaging without compromising their mobility.
T2*-weighted MR imaging is routinely used to depict the presence of iron in the hepatic
parenchyma. However, the paramagnetic signal intensity on T2*-weighted imaging has been
shown to depend on microsphere size and the degree of microsphere aggregation. Moreover,
this paramagnetic effect is influenced by the strength of the magnetic field, the magnetic
property of the core, and echo time (11,23). In our study, there was positive MR imaging and
histopathologic correlation in both groups for the distribution of IOEs in the tumor bed.
However, MR imaging was weaker in demonstrating the presence of IOEs in group S compared
with pathologic analysis. One could attribute this discrepancy to (i) the low signal-to-noise
ratio of these microspheres when lodged inside the tumor, (ii) their size, or (iii) the low
aggregation effect caused by individual trapping of smaller microspheres inside the tumor
vessels. Individually trapped, isolated IOEs may be hard to detect on MR imaging as a result
of low signal-to-noise ratio of a single small particle or slice misregistration. Further studies
should be performed to confirm these assumptions.
In the present study, we clearly demonstrated that small Embospheres lodged inside the tumor
(including the rim of the tumor), whereas their larger counterparts remained outside the tumor.
Nevertheless, the optimal sphere size for any given hepatic tumor remains to be determined.
This might be difficult to assess only by estimating vessel size, observing the slowing of arterial
flow, or depicting deeper penetration of smaller IOEs into the abnormal tumor vascular bed.
Further studies should be performed to accurately correlate microsphere size, level of arterial
obstruction, and tumoricidal effect. Nonetheless, we can state that, if the purpose of
embolization is to deliver microspheres as close to the tumor as possible or even within the
tumor bed, the small particles measuring 100–300 µm should be used. In this regard, our finding
may have some important implications for new drug delivery systems. Again, knowing that
drugs cannot travel long distances within the tumor microenvironment, it is essential and highly
desirable to deliver them as close to the tumor as possible. A single previous report (22)
demonstrated that the level of vascular occlusion with calibrated tris-acryl microspheres
precisely correlated with particle size. We could therefore infer from that report that 100-µm
particles should occlude vessels of matching size. Yet, it is important to note that tumors
demonstrate a large degree of random variation in vessel length and diameter, making precise
matching more difficult. Tumor blood flow is also highly variable and often consists of leaky
irregular sinuses with incomplete basement membranes. Moreover, in a clinical setting, large
hepatocellular carcinomas may be accompanied by intratumoral arterioportal or arteriovenous
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shunts, and caution should be paid when choosing the smaller size of embolic particles. Such
aspects of the tumor microenvironment must be considered when choosing microspheres based
on size for penetration inside tumors.
The present study has several limitations. The embolic and/or tumoricidal effects of these
microspheres were not studied. Further investigations should be performed to demonstrate
whether the increased distal arterial embolization provided by the use of the smaller IOEs
allows greater tumor kill. Long-term MR imaging follow-up and histopathologic analysis was
also not performed, as the study is focused on microsphere detectability and preferential
distribution. In this study, we also chose not to calculate liver iron concentration or estimate
hepatic iron content with proton transverse relaxation rate R2 images, as our aim was to
qualitatively and not quantitatively analyze the IOE distribution.
In summary, we found that iron-loaded tris-acryl gelatin microspheres could easily be tracked
by MR imaging, allowing immediate determination of the distribution of the microspheres in
the liver. We also found that the distribution of these microspheres differed greatly according
to their respective size. The smaller microspheres (100–300 µm) were found delivered within
the tumor itself or, at the very minimum, within the rim of the tumor, whereas the 300–500-
µm microspheres clustered within the hepatic artery outside the tumor. This preferential
distribution may have important clinical implications, especially regarding drug delivery with
use of drug-eluting microspheres.
Abbreviation
IOE, iron oxide– containing Embosphere.
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Hepatic artery digital subtraction angiography in a rabbit. (a) Digital subtraction angiographic
image of the celiac axis demonstrates typical rabbit hepatic arterial anatomy. The VX2 tumor
stain is visible within the left lateral lobe of the liver. (b) On digital subtraction angiographic
image at the proper hepatic artery before treatment, note the intense tumor blush within the left
lateral lobe of the liver.
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Axial T2*-weighted MR image (field of view, 16 × 16; matrix size, 256 × 160; repetition/echo
time, 200/15 msec; flip angle, 45°) of the liver after embolization with 100–300-µm IOEs.
Note the multiple punctate signal voids inside the tumor (arrowheads) and circumferentially
distributed at the rim of the tumor (white arrows), showing the ability of MR imaging to track
the distribution of IOEs in tumor bed.
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Axial T2*-weighted MR image of the liver after embolization with 300–500-µm IOEs. Less
intense and partially distributed signal void at the rim of the tumor (arrowhead) is seen without
signal void inside the tumor. Note the intense signal void with blooming artifact (white arrow)
caused by the clustered IOEs within the left hepatic artery located at a significant distance from
the tumor bed.
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MR Imaging and histopathologic correlation in an animal in group S treated with 100–300-µm
IOEs. Good deposition of particles in the tumor bed at the intracapsular deposition of periphery
of the tumor and inside the tumor. Prussian blue staining demonstrates iron-loaded blue-colored
embolic materials.
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(300 –500-µm IOE) P Value
MR Imaging
   MR sensitivity 10/10 (100) 10/10 (100)
   Quantification score 20 16 <.05
   Artifact in artery 10/10 (100) 10/10 (100)
   Artifact in tumor bed <.05
      Periphery of tumor 10/10 (100) 6/10 (60)
      Inside tumor 3/10 (30) 0/10
Histopathology
   Quantification score 20 14 <.05
   IOEs in artery 10/10 (100) 10/10 (100)
   IOEs in tumor bed <.05
      Periphery of tumor 10/10 (100) 4/10 (40)
      Inside tumor 7/10 (70) 0/10
Note.—Values in parentheses are percentages.
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